DRMA:NASDAQ, Dermata Therapeutics, Inc.

DRMA stock overview

Dermata Therapeutics, Inc. (DRMA:NASDAQ) closed at $0.800 on October 21, 2026, down 8.09% on the day. The stock trades 82.8% below its 52-week high of $4.66 and 32.6% above its 52-week low of $0.603. Over the past year, it lost 78.8%. Dermata Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.800
Day change
-8.09%
Volume
214,932
Average volume
3,427,639
Market cap
3M+
52-week range
$0.603 – $4.66
50-day average
$1.20
200-day average
$1.37

Price action over the past year

In 252 trading sessions since October 21, 2025, DRMA closed higher on 100 days (40%). Its best day was February 19, 2026 (+50.78%) and its worst was February 20, 2026 (-30.05%). The stock moved 10% or more in a single session 30 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

DRMA news

About Dermata Therapeutics, Inc.

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.

Similar stocks

Find more stocks like DRMA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.